Profil
Igor Gonda served as the President, Chief Executive Officer & Director of Aradigm Corp.
from 2006 to 2018.
Prior to that, he was the Chief Executive Officer & Managing Director of Acrux Ltd.
from 2001 to 2006.
He also worked as a Senior Scientist at Genentech, Inc. from 1992 to 1995.
Gonda received his undergraduate and doctorate degrees from the University of Leeds.
Anciens postes connus de Igor Gonda
| Sociétés | Poste | Fin |
|---|---|---|
| ARADIGM CORPORATION | Chief Executive Officer | 11/02/2018 |
| ACRUX LIMITED | President | 01/08/2006 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/09/1995 |
Formation de Igor Gonda
| University of Leeds | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACRUX LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
